Histidine

CAS 71-00-1 5 current records 1 historicalSmall Molecule

Who holds supplier records for Histidine? 5 organisations hold a current record for Histidine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Japan (2), Germany (1), United States (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Histidine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/histidine

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Histidine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Histidine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Histidine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AJINOMOTO CO., INC. Chuo-KuJP
CEP 1998-107 - Rev 05
Histidine
Aug 2026—
SHANGHAI PLUMINO AMINO ACID CO., LTD. ShanghaiCN
CEP 2010-047 - Rev 02
Histidine Hydrochloride Monohydrate
Oct 2025Inspected Mar 2024
Germany
AMINO GMBH FrellstedtDE
R1-CEP 2016-114 - Rev 00
Histidine
Nov 2022—
KYOWA HAKKO BIO CO., LTD. TokyoJP
R1-CEP 1999-026 - Rev 05
Histidine Hydrochloride Monohydrate
Jun 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Histidine are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • DEGUSSA AG WERK RADEBEUL
    Inactive DMF 3888, 3920 · filed Aug 1980

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Histidine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL17962).

Chemical identity

IUPAC name
(2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid
Canonical SMILES
C1=C(NC=N1)C[C@@H](C(=O)O)N
InChIKey
HNDVDQJCIGZPNO-YFKPBYRVSA-N
Synonyms
FEMA NO. 3694, Histidina, Histidine, L-histidine, NSC-137773, glyoxaline-5-alanine, L-(-)-Histidine, Istidina, HISTIDINE, L-, L-Histidin, (S)-4-(2-Amino-2-carboxyethyl)imidazole, Histidinum

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Histidine?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Histidine: AMINO GMBH (Germany), AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INC (United States), AJINOMOTO CO INC (Japan), Kyowa Hakko Bio Co., Ltd. (Japan) and Shanghai Plumino Amino Acid Co.,Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Histidine Drug Master Files are active?

AMINO GMBH (DMF 39086) and AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INC (DMF 31562). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Histidine records mean?

1 organisation has only inactive Type II DMFs for Histidine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Histidine have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Histidine on the EDQM register, including AJINOMOTO CO., INC. Chuo-Ku (JP), SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai (CN), AMINO GMBH Frellstedt (DE) and KYOWA HAKKO BIO CO., LTD. Tokyo (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Histidine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Histidine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.